Everything You Need to Know About Scotland Life SciencesBeckie Barrett2025-07-08T10:22:58+01:00June 27th, 2025|Article, BioCity Glasgow, Edinburgh Technopole|
Scottish Company Taking Years Off Drug DevelopmentGrace Crocker2025-06-17T14:03:23+01:00June 17th, 2025|BioCity Glasgow, News|
BioAscent Significantly Outperforms Market Despite Challenging Market ConditionsBeckie Barrett2025-03-14T13:56:21+00:00March 14th, 2025|Article, BioCity Glasgow, News|
BioAscent Reports Promising Growth As It Marks Tenth AnniversaryVicky Coghlan2024-11-28T14:23:27+00:00April 15th, 2024|BioCity Glasgow, Investment, News|
Scotland’s Thriving Life Sciences Sector Defies PredictionsVicky Coghlan2024-03-21T15:55:33+00:00March 21st, 2024|BioCity Glasgow, Edinburgh Technopole, Investment, News|
BioCity Glasgow: BioAscent Invests In New State-Of-The-Art Protein Production FacilityVicky Coghlan2024-11-28T14:25:44+00:00February 23rd, 2024|BioCity Glasgow, Investment, News|
Virax Biolabs Group Establishes R&D Facility At Pioneer Group’s BioCity GlasgowVicky Coghlan2024-11-28T14:36:01+00:00August 24th, 2023|BioCity Glasgow, News|
How Creative Incubation Supports Life Sciences In The UKVicky Coghlan2024-11-28T14:38:23+00:00July 13th, 2023|Accelerator, BioCity Glasgow, Investment, News|
Pioneer Group Secures Planning Permission For 72,800 sq. ft. Of Lab Space In GlasgowGemma Cann2024-12-02T12:38:34+00:00June 26th, 2023|BioCity Glasgow|
Commercializing The Success Of Scottish Life Sciences Will Rely On Scale-Up Space And Government DirectionVicky Coghlan2024-11-28T14:19:20+00:00June 14th, 2023|Article, BioCity Glasgow, Edinburgh Technopole, Investment|
